Trade Summary

4 days ago, Balcom Alexandra, serving as Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 11,430 shares at $98.69 per share, for a total transaction value of $1,128,080.49. Following this transaction, Balcom Alexandra now holds 85,533 shares of NUVL.

This sale represents a 11.79% decrease in Balcom Alexandra's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 1, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 at 4:30 PM ET, 2 days after the trade was made.

Nuvalent, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.